BONESUPPORT launched a 5mL version of CERAMENT™|G antibiotic-eluting bone substitute in the EU. The smaller volume option expands the application of the injectable product in small joint and extremity indications.
BONESUPPORT expects to initiate a pivotal U.S. clinical trial for CERAMENT|G in 2Q16.
Source: BONESUPPORT AB
BONESUPPORT launched a 5mL version of CERAMENT™|G antibiotic-eluting bone substitute in the EU. The smaller volume option expands the application of the injectable product in small joint and extremity indications.
BONESUPPORT expects to initiate a pivotal U.S. clinical...
BONESUPPORT launched a 5mL version of CERAMENT™|G antibiotic-eluting bone substitute in the EU. The smaller volume option expands the application of the injectable product in small joint and extremity indications.
BONESUPPORT expects to initiate a pivotal U.S. clinical trial for CERAMENT|G in 2Q16.
Source: BONESUPPORT AB
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.